Science & Quality
Developed, made, tested, released — and watched after it reaches a patient.
From molecule to patient
-
01 Developed Gaps identified, actives sourced, delivery systems designed. -
02 Made Cleanroom manufacture at approved partner facilities. -
03 Tested Every batch checked against monograph before release. -
04 Released Sealed, warehoused and shipped under GDP. -
05 Monitored Adverse events recorded, investigated and answered.
Two years, on the clock
Held at 40°C ± 2°C and 75% ± 5% relative humidity (Zone IVB) — the accelerated condition for the climate our products actually ship into.
Control samples from every batch manufactured are held in an environmentally controlled repository for verification against any market complaint.
What we commit to, in writing
- Serious adverse event escalated Within 24 hours.
- Any report acknowledged Within 48 hours.
- Substantive response given Within 15 days.
What a batch is measured against
- IP
- BP
- USP
Indian, British and United States Pharmacopoeia monographs.
We partner with manufacturing plants approved under the World Health Organization's Good Manufacturing Practices (WHO-GMP) and the DCGI. Products are manufactured in sterile, humidity-controlled cleanrooms using automated machinery, and pilot batches are validated before mass manufacturing begins.
- High-performance liquid chromatography (HPLC)
- Dissolution apparatus
- Disintegration apparatus
- Tablet hardness tester
- Friability tester
- Viscometer for gels and sprays
- Fill-weight and uniformity check station
- Packaging material testing — thickness, tensile strength and pinhole leak
- Environmental stability chambers